Compare COCP & ORIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCP | ORIO |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6M | 20.5M |
| IPO Year | 2011 | 2014 |
| Metric | COCP | ORIO |
|---|---|---|
| Price | $1.18 | $1.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 54.9K | ★ 99.7K |
| Earning Date | 05-15-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,712,091.00 | N/A |
| Revenue This Year | N/A | $74.52 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | ★ N/A | $4.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $0.61 |
| 52 Week High | $2.03 | $1.40 |
| Indicator | COCP | ORIO |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 55.86 |
| Support Level | $0.91 | $0.82 |
| Resistance Level | $1.22 | $1.12 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 36.84 | 54.93 |
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.